Elucidating Extracellular Matrix and Stiffness Control of Primary Human Hepatocyte Phenotype via Cell Microarrays
- 22 October 2021
- journal article
- research article
- Published by Wiley in Advanced Materials Interfaces
- Vol. 8 (22) , 2101284
Abstract
How the liver's extracellular matrix (ECM) protein composition and stiffness cooperatively regulate primary human hepatocyte (PHH) phenotype is unelucidated. Here, protein microarrays and high‐content imaging with single‐cell resolution are utilized to assess PHH attachment/functions on 10 major liver ECM proteins in single‐ and two‐way combinations robotically spotted onto polyacrylamide gels of 1 or 25 kPa stiffness. Albumin, cytochrome‐P450 3A4 (CYP3A4), and hepatocyte nuclear factor alpha (HNF4α) positively correlate with each other and cell density on both stiffnesses. The 25 kPa stiffness supports higher average albumin and HNF4α expression after 14 d, while ECM protein composition significantly modulates PHH functions across both stiffnesses. Unlike previous rodent data, PHH functions are highest only when collagen‐IV or fibronectin are mixed with specific proteins, whereas noncollagenous proteins without mixed collagens downregulate functions. Combination of collagen‐IV and hyaluronic acid retains high CYP3A4 on 1 kPa, whereas collagens‐IV and ‐V better retain HNF4α on 25 kPa over 14 d. Adapting ECM conditions to 96‐well plates containing conjugated hydrogels reveals novel regulation of other functions (urea, CYP1A2/2A6/2C9) and drug‐mediated CYP induction by the ECM protein composition/stiffness. This high‐throughput pipeline can be adapted to elucidate ECM's role in liver diseases and facilitate optimization of engineered tissues.Keywords
This publication has 47 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosisLaboratory Investigation, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- HNF4α—role in drug metabolism and potential drug target?Current Opinion in Pharmacology, 2010
- Liver stiffness: a novel parameter for the diagnosis of liver diseaseHepatic Medicine: Evidence and Research, 2010
- Maintenance of Human Hepatocyte Function In Vitro by Liver-Derived Extracellular Matrix GelsTissue Engineering Part A, 2010
- Functional Modulation of ES-Derived Hepatocyte Lineage Cells via Substrate Compliance AlterationAnnals of Biomedical Engineering, 2008
- Liver extracellular matrix in health and diseaseThe Journal of Pathology, 2003
- Extracellular Matrix Gradients in the Space of Disse: Relevance to Liver BiologyHepatology, 1992
- Tenascin expression in human chronic liver disease and in hepatocellular carcinomaLiver International, 1992